Rosalind Advisors’s Viridian Therapeutics VRDN Stock Holding History

Rosalind Advisors’s Portfolio VRDN Stock Details VRDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$9.79M	Buy
2025 Q1	$8.02M	Buy
2024 Q3	–	Sell
2024 Q2	$3.9M	Hold
2024 Q1	$5.25M	Sell
2023 Q4	$7.85M	Buy